Strategic Analysis of the Massachusetts Research Credit Liability Cap and its Regulatory Framework

The Massachusetts Research Credit liability cap restricts corporations from offsetting more than 100% of their first $25,000 in excise tax plus 75% of any remaining balance. This mechanism ensures that high-liability entities maintain a minimum cash contribution to the Commonwealth while allowing for the indefinite preservation of disallowed credit portions.

The complexity of the Massachusetts Research Credit, primarily codified under Massachusetts General Laws (M.G.L.) Chapter 63, Section 38M, reflects a sophisticated balance between providing aggressive incentives for innovation and maintaining stable state revenue streams.1 Unlike the federal research credit, which serves as a broad incentive across the United States, the Massachusetts variant is strictly localized to activities performed within the Commonwealth.3 The liability cap—the “$25,000 plus 75% rule”—is not merely a limit on the immediate utility of the credit but a structured deferral system that distinguishes between different types of unused credits.1 To understand the application of this law, one must analyze the interplay between the statutory language of Section 38M, the Department of Revenue’s (DOR) regulatory interpretations in 830 CMR 63.38M.1 and 63.38M.2, and the evolving judicial landscape regarding entity eligibility.5

Statutory Foundation and Economic Objectives of Section 38M

The primary objective of M.G.L. c. 63, § 38M is to stimulate investment in research and development (R&D) within Massachusetts by providing a dollar-for-dollar offset against corporate excise liabilities.1 The credit is available to domestic and foreign corporations subject to the corporate excise, as well as to members of combined groups and flow-through entities.1 For most of its history, the credit was perceived as an incentive for traditional manufacturing and technology firms.1 However, the definition of an eligible “business corporation” has recently been clarified to include financial institutions, as confirmed by the Appellate Tax Board in State Street Corporation v. Commissioner of Revenue.6

The credit is calculated based on two primary components: qualified research expenses (QREs) and basic research payments.10 Massachusetts largely adopts the definitions provided in Section 41 of the Internal Revenue Code (IRC), though with a strict geographic nexus.5 This means that for an expense to qualify, the research activity must be conducted at a facility or site physically located within Massachusetts.1 The adoption of federal standards ensures a level of predictability for multi-state firms, while the state-specific caps and carryover rules tailor the incentive to the Commonwealth’s unique fiscal requirements.13

Component Massachusetts Definition Federal Alignment (IRC § 41) Citation
Qualified Research Expenses (QREs) In-state wages, supplies, and computer rental costs Direct alignment on activity types 7
Basic Research Payments Payments to qualified non-profit organizations for research Direct alignment on recipient types 7
Geographic Nexus Strictly limited to Massachusetts activity National (any US activity) 3
Calculation Methodology Regular Method or Alternative Simplified Method (ASM) Modeled after federal ASM 4

The Mechanics of the Liability Cap: The $25,000 Plus 75% Formula

The liability cap is the most critical constraint on the utilization of the Massachusetts Research Credit.1 It functions as a non-waivable limit on the amount of credit a taxpayer may claim in any single taxable year.2 The formula is explicitly designed to allow smaller taxpayers to eliminate their tax liability (subject to the minimum tax floor) while requiring larger taxpayers to contribute a portion of their marginal excise in cash.1

The statutory language of Section 38M(e) provides that the credit is limited to 100% of the first $25,000 of excise, plus 75% of the excise exceeding $25,000.2 This calculation must be performed using the “corporate excise liability,” which is the total excise determined before the application of any credits.5 This base includes both the income measure and the non-income (property or net worth) measure of the corporate excise.5

For a corporation with a total excise liability ($E$) of $100,000, the maximum credit ($C_{max}$) it could utilize is calculated as follows:

  • 100% of the first $25,000 = $25,000.
  • 75% of the remaining $75,000 ($100,000 – $25,000) = $56,250.
  • Total $C_{max} = $25,000 + $56,250 = $81,250.

In this scenario, even if the corporation had $200,000 in generated R&D credits, it would still be required to pay $18,750 in excise tax ($100,000 total liability minus $81,250 maximum credit).1 This required payment represents the 25% of the excess liability that the credit is prohibited from covering.4

Local State Revenue Office Guidance and Regulatory Interpretation

The Massachusetts Department of Revenue has issued several key documents that define the practical application of this cap.4 Regulation 830 CMR 63.38M.1 and the proposed 830 CMR 63.38M.2 provide the primary framework for these calculations.5 These regulations emphasize that the $25,000 threshold is not a per-corporation allowance in all cases, but rather a shared pool for related entities.1

Aggregated Groups and the Unitary $25,000 Bracket

One of the most complex aspects of the guidance involves “aggregated groups”.5 According to 830 CMR 63.38M.1(8), members of a controlled group (as defined under IRC § 41(f)) or entities under common control must share a single $25,000 threshold.4 This prevents corporate taxpayers from splitting their operations into multiple legal entities to claim multiple $25,000 full-offset brackets.1

The shared $25,000 amount is allocated among the group members based on their respective excise liabilities.4 If a member corporation has zero excise liability, it receives none of the bracket.5 The allocation formula is strictly proportional:

$$Member’s\ Shared\ Threshold = \$25,000 \times \left( \frac{Member’s\ Separately\ Determined\ Excise}{Total\ Excise\ of\ All\ Group\ Members} \right)$$

This proportional allocation ensures that the “100% offset” benefit is distributed fairly among the entities that actually owe tax to the Commonwealth.4 Once this threshold is exhausted, every member of the group is subject to the 75% limitation on their remaining liability.1

Interaction with Combined Reporting

For corporations filing a combined return under M.G.L. c. 63, § 32B, the research credit usage is subject to additional constraints.2 Credits generated by an individual member must first be applied against that member’s own portion of the group’s excise.2 If a member has “excess” credits after offsetting its own liability (subject to the 75% cap), those credits may be shared with other members of the group.2 However, the recipient member can only use those shared credits up to its own $25,000/75% limit.4 This ensures that the combined group as a whole does not circumvent the liability cap by shifting credits between members.1

The Minimum Excise Floor: A Hard Constraint

While the liability cap defines the maximum credit usage, the law also establishes a “minimum excise” floor that can never be breached by the research credit.1 Under current Massachusetts law, the minimum excise is $456.1 This means that no matter how many credits a corporation has, its final tax bill (before other adjustments like penalties) cannot be less than $456.4

This floor applies to each entity filing a separate return or to each member of a combined group.4 It serves as a fundamental principle of the Massachusetts tax code: every corporation enjoying the benefits of doing business in the Commonwealth must contribute a baseline amount to the state’s administrative costs.1 The interaction of the 75% cap and the $456 floor creates a “donut hole” effect for very small taxpayers, where they can offset nearly all of their tax but must always retain that final $456 payment.4

The Strategic Importance of Bifurcated Carryover Rules

Perhaps the most unique and insight-rich aspect of the Massachusetts Research Credit is its treatment of unused credits.1 The law creates a vital distinction between credits that are unused because they exceed the total tax liability and those that are unused because of the 75% cap.1

The 15-Year Standard Carryover

Credits that cannot be used because they exceed the corporation’s actual excise liability for the year (after applying the 75% cap) may be carried forward for 15 years.1 For instance, if a company has a max credit allowance of $50,000 but has generated $100,000 in credits, the remaining $50,000 enters this 15-year window.1 If these credits are not used within that timeframe, they expire and provide no further benefit.3

The Indefinite (Unlimited) Carryforward

A far more advantageous rule applies to credits disallowed specifically because of the 75% limitation on excise exceeding $25,000.1 Any portion of the credit that would have been allowable if not for that percentage cap may be carried forward indefinitely.1 This means that the 25% of the “excess” excise that a company is forced to pay in cash effectively generates a non-expiring tax asset.1

This “Unlimited” status is a powerful planning tool for mature, highly profitable companies.1 It ensures that the 75% cap acts as a timing mechanism rather than a permanent tax increase.1 Over a long enough horizon, a corporation that remains in Massachusetts will eventually be able to utilize these “banked” credits, provided its future R&D spending decreases or its tax liability structure changes.1

Feature Standard Carryforward Unlimited (Indefinite) Carryforward Citation
Duration 15 Taxable Years Limitless Period 1
Trigger Credit exceeds total potential excise offset Disallowed by the 75% rule on excess excise 1
Economic Value Time-limited; risks expiration Permanent; provides long-term floor value 1
Accounting Requires tracking of vintage (year generated) Requires tracking of specific “cap-denied” status 1

Calculation Methodologies: Regular vs. Alternative Simplified Method (ASM)

To effectively navigate the liability cap, a taxpayer must first correctly calculate the credit itself.4 Massachusetts provides two distinct options, modeled after the federal system but with state-specific rates and historical base periods.1

The Traditional (Regular) Method

Under the traditional method, the credit is equal to 10% of the difference between the current year’s Massachusetts QREs and a “base amount”.1 This method also includes a 15% credit for basic research payments made to universities or hospitals.1 The base amount is calculated using a “fixed-base ratio” and average gross receipts from the four years preceding the credit year.4

A critical nuance in the Regular Method is the “Minimum Base Amount” rule.5 In no event can the base amount used in the calculation be less than 50% of the current year’s QREs.5 This ensures that even for rapidly growing firms, the credit is only applied to incremental R&D spending rather than the entire R&D budget.1

The Alternative Simplified Method (ASM)

For tax years beginning on or after January 1, 2015, Massachusetts introduced the ASM as an alternative to the cumbersome historical data requirements of the Regular Method.11 The ASM rate has been phased in over a seven-year period to reach its current permanent level.12

Calendar Years ASM Credit Rate Calculation Base Citation
2015 – 2017 5.0% QREs exceeding 50% of 3-year average 11
2018 – 2020 7.5% QREs exceeding 50% of 3-year average 11
2021 and after 10.0% QREs exceeding 50% of 3-year average 11

The ASM is often preferred by volatile or newer companies because it only requires data from the three preceding taxable years.1 If a corporation did not have QREs in any of the three preceding years, the ASM credit is capped at 5% of the current year’s QREs.4 The election to use the ASM is generally made on the original return and is binding for that year.4

Specialized Industry Provisions: Life Sciences and Climatetech

The Massachusetts legislature has recognized that the standard 75% cap and non-refundable nature of the credit can be a barrier for early-stage companies in critical sectors.1 As such, specialized refund programs exist that fundamentally alter the credit’s value proposition.1

The Massachusetts Life Sciences Center (MLSC) Refund Election

Certified life sciences companies may apply annually to the MLSC for a refund of their excess R&D credits.1

  • Mechanism: If awarded, the company can receive a refund equal to 90% of the remaining balance of its credits.11
  • Eligibility: The company must be “certified” under the Life Sciences Tax Incentive Program, which involves commitments to job creation and capital investment in Massachusetts.1
  • Impact: This bypasses the 75% cap by allowing the company to monetize credits that would otherwise be stuck in a 15-year carryforward window.1

The 2024 Climatetech Initiative

Modeled after the Life Sciences program, the 2024 Economic Development Act established a similar framework for “Climatetech” companies.26

  • Climatetech QRE Credit: This credit utilizes the same $25,000/75% cap and ASM/Regular calculation methods.26
  • Refundability: Certified Climatetech companies may also opt for a 90% refund of excess credits if authorized by the Climatetech Tax Incentive Program.2
  • Job Commitment: Eligibility is tied to a commitment to create at least 5 net new permanent full-time employees in Massachusetts.26

These industry-specific overrides to the general liability cap represent a targeted economic strategy: while most corporations must wait to realize the value of their credits, high-priority startups can access capital immediately to fuel further innovation.1

Comprehensive Case Study: Multi-Entity Combined Group

To illustrate the full complexity of the Massachusetts Research Credit liability cap, consider a combined group, “BioNexus Global,” which consists of three members filing a combined report in 2024.5

Entity Profiles

  1. BioNexus Parent (Entity A): A holding and management company with an excise liability of $50,000. It generated no R&D credits this year.
  2. BioLabs MA (Entity B): The primary research subsidiary. It has an excise liability of $150,000 and generated $200,000 in R&D credits.
  3. BioProd MA (Entity C): A manufacturing subsidiary. It has an excise liability of $100,000 and has $20,000 in R&D credits carried forward from a prior year.

Step 1: Calculate the Shared $25,000 Bracket

Total group excise = $50k (A) + $150k (B) + $100k (C) = $300,000.4

The $25,000 bracket is allocated as follows 4:

  • Entity A Share: $25,000 * ($50k / $300k) = $4,167
  • Entity B Share: $25,000 * ($150k / $300k) = $12,500
  • Entity C Share: $25,000 * ($100k / $300k) = $8,333

Step 2: Calculate Maximum Credit for Each Entity (The Cap)

Each entity can offset 100% of its shared share, plus 75% of its remaining excise.1

  • Entity A Max Offset: $4,167 + 0.75 * ($50,000 – $4,167) = $4,167 + $34,375 = $38,542
  • Entity B Max Offset: $12,500 + 0.75 * ($150,000 – $12,500) = $12,500 + $103,125 = $115,625
  • Entity C Max Offset: $8,333 + 0.75 * ($100,000 – $8,333) = $8,333 + $68,750 = $77,083

Step 3: Credit Application and Sharing

Entity B has $200,000 in credits but is capped at $115,625 for its own tax.2

  • Entity B uses $115,625.
  • Residual Credit for Entity B = $200,000 – $115,625 = $84,375.
  • Of this residual, the portion denied specifically by the 75% rule ($150k – $12.5k = $137.5k excess; 25% of $137.5k = $34,375) becomes Unlimited Carryforward.1
  • The remaining $50,000 of Entity B’s credit ($84,375 – $34,375) can be shared with Entity A and Entity C.4

Entity C uses its own $20,000 carryover first.4 It has “room” for $57,083 more credit ($77,083 cap – $20,000 used). It takes $50,000 from Entity B.4

Entity A has no credits but can take the last of the shared pool if any were left. In this case, the pool is exhausted.4

Step 4: Final Tax Positions

  • Entity A Tax: $50,000 – $0 credits = $50,000
  • Entity B Tax: $150,000 – $115,625 credits = $34,375
  • Entity C Tax: $100,000 – ($20,000 own + $50,000 shared) = $30,000
    All entities are above the $456 minimum tax, so the results stand.4

Statistical Overview and Fiscal Significance

The Massachusetts Research Credit is one of the most utilized tax expenditures in the state budget, reflecting the high concentration of technology and life sciences firms.23 Data from the FY2025 Tax Expenditure Budget highlights the significant scale of these offsets.23

Fiscal Year Research Credit Expenditure (Millions) Overall Corporate Credits (Millions) Citation
FY 2021 $530.0 (est.) $801.4 23
FY 2022 $580.0 (est.) $880.4 23
FY 2024 $586.0 $2,000.0+ (all types) 23
FY 2025 $644.6 $3,596.8 (all types) 23

The jump in expenditure between FY2024 and FY2025 is partially attributed to the expanded eligibility of financial institutions following the State Street Corp decision.6 Additionally, the permanent 10% ASM rate has encouraged more firms to claim the credit rather than opting for the more complex Regular Method.15

The growth of the expenditure despite the 75% liability cap suggests that the cap is not a deterrent to R&D investment.1 Instead, the cap serves as a mechanism for the state to manage cash flow while providing corporations with long-term certainty through the indefinite carryforward of disallowed credits.1

Interaction with Other Major Credits: The Investment Tax Credit (ITC)

Corporations that qualify for the Research Credit frequently also qualify for the Investment Tax Credit (ITC) under M.G.L. c. 63, § 31A.15 The ITC allows a 3% credit for the purchase or lease of qualifying tangible property (buildings, machinery, equipment) used in R&D or manufacturing.18

There is a critical difference in the liability caps of these two credits 1:

  • Research Credit Cap: $25,000 + 75% of excess.1
  • ITC Cap: 50% of total excise.15

Because the research credit cap is more generous (allowing a 75% offset on the bulk of the liability), it is often more valuable on a per-dollar basis than the ITC.1 However, the ITC carryforward rules are more restrictive—standard ITC credits expire after 3 years, though any portion disallowed by the 50% cap can be carried forward indefinitely.15

Strategic taxpayers often sequence their credit usage by applying the ITC first to maximize the utilization of short-lived credits, provided the combined offset does not exceed the most restrictive applicable cap.1 However, the DOR regulations clarify that the research credit cap calculation is based on the excise before any other credits, which provides a helpful firewall between these incentives.5

Recent Judicial and Administrative Shifts: Financial Institutions

A major development in 2024 and 2025 has been the inclusion of financial institutions in the research credit program.6 Historically, the DOR had argued that financial institutions, which are taxed under M.G.L. c. 63, § 2, were distinct from “business corporations” taxed under § 39, and thus ineligible for the § 38M credit.6

In State Street Corporation v. Commissioner of Revenue (2024), the Appellate Tax Board rejected this view.6 The Board ruled that the definition of a business corporation in M.G.L. c. 63, § 30(1) is broad enough to include banks and other financial entities, provided they meet the other requirements of the R&D credit.6

The DOR’s response, codified in TIR 25-3, has significant implications for the liability cap:

  • Amended Returns: Financial institutions can now file amended returns to claim the credit for past years.6
  • ASM Election: The DOR has waived the requirement that the ASM election be made on an original return for these institutions, allowing them to elect ASM on amended returns.6
  • Liability Base: For financial institutions, the “excise liability” used for the 75% cap is the 9% net income excise, which cannot be less than the $456 minimum tax.6

This decision significantly increases the aggregate amount of research credits that will be claimed in Massachusetts, potentially leading to further legislative scrutiny of the 75% cap in future years.23

Compliance and Recordkeeping: Defending the Credit

Given the high value and “Unlimited” carryover potential of the research credit, it is a frequent target for DOR audits.1 Taxpayers must maintain a comprehensive audit trail to justify their credit claims.1

The “Four-Part Test” Documentation

The DOR requires evidence that every project claimed meets the criteria of IRC § 41 10:

  1. Technological in Nature: The research must rely on engineering, biological, or computer science.1
  2. Permitted Purpose: The goal must be to create a new or improved product, process, or software.1
  3. Elimination of Uncertainty: The researchers must have faced a technical challenge they did not know how to solve at the outset.1
  4. Process of Experimentation: The researchers must have used an iterative process (prototyping, testing, modeling) to resolve the uncertainty.1

Quantitative Substantiation

For the purposes of the liability cap, accurate wage and supply tracking is paramount.3 The DOR expects contemporaneous time logs or sophisticated statistical sampling to support the percentage of employee time dedicated to R&D.14 Invoices for supplies must demonstrate that the items were used or consumed in Massachusetts.1 If a contractor performs research, only 65% of the invoice is eligible, and the taxpayer must prove that the work was physically performed at a Massachusetts site.7

Conclusion: Strategic Implications of the Massachusetts Framework

The Massachusetts Research Credit’s liability cap of $25,000 plus 75% is a distinctive feature of the Commonwealth’s tax policy that requires ongoing attention from corporate tax departments.1 While the cap limits immediate liquidity, the “Unlimited” carryforward provision for disallowed portions offers a unique form of long-term tax security that is rare in other state jurisdictions.1

For companies operating in Massachusetts, the credit should be viewed as more than just a year-end tax calculation; it is a strategic asset that must be managed through careful project tracking, entity-level liability planning, and informed decision-making between the Regular and ASM methods.8 The recent inclusion of financial institutions and the creation of the Climatetech refund program demonstrate that the Massachusetts R&D incentive landscape remains dynamic, offering new opportunities for a wide range of industries to lower their cost of innovation while contributing to the state’s economic vitality.1


Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars

Choose your state

find-us-map